Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

204
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
204
Obesity01:24

Obesity

401
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
401

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing plant protein sources in the diet modulates gut microbiota and tryptophan metabolism in men at cardiometabolic risk.

Gut microbes·2026
Same author

Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG.

United European gastroenterology journal·2026
Same author

Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas.

International journal of cancer·2026
Same author

Tumor-associated macrophages in head and neck carcinoma: clinicopathological correlations and implications for immunotherapy.

Cancer immunology, immunotherapy : CII·2026
Same author

Comparison of radiological and pathological tools to assess response to neoadjuvant treatment in resected pancreatic ductal adenocarcinoma patients.

Therapeutic advances in medical oncology·2026

Related Experiment Video

Updated: Jun 12, 2025

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

15.5K

Orexins mitigate obesity-associated dysfunctions in mice.

Anne Blais1, Isabelle Denis1, Mireille Andriamihaja1

  • 1UMR-PNCA, Université Paris-Saclay, AgroParisTech, Palaiseau, France.

Obesity (Silver Spring, Md.)
|September 24, 2024
PubMed
Summary

Orexin-A treatment reduced weight gain and improved metabolic health in obese mice. This suggests orexin receptors are potential therapeutic targets for treating obesity and its related complications.

More Related Videos

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

16.1K
Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

8.9K

Related Experiment Videos

Last Updated: Jun 12, 2025

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

15.5K
Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

16.1K
Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
08:06

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

8.9K

Area of Science:

  • Neuroscience
  • Metabolic Research
  • Obesity Studies

Background:

  • Obesity is a widespread chronic disease with significant comorbidities.
  • Orexins, hypothalamic neuropeptides, play a role in physiological processes linked to obesity.

Purpose of the Study:

  • To investigate the effects of chronic orexin-A administration in mouse models of obesity.
  • To evaluate the role of orexin signaling in metabolic flexibility.

Main Methods:

  • Utilized obesity-prone and resistant C57BL/6 mice, and orexin receptor-deficient mice fed a high-fat diet.
  • Assessed glucose tolerance, indirect calorimetry, neuropeptide/receptor expression, microglial activation, and gut microbiota.

Main Results:

  • Orexin-A administration decreased weight gain, body fat, food intake, and insulin resistance in obesity-prone mice.
  • Observed alterations in intestinal microbiota composition and reduced hypothalamic expression of orexin receptors and feeding-related neuropeptides.
  • Orexin-A treatment mitigated steatosis and improved metabolic flexibility.

Conclusions:

  • Orexin receptor signaling is implicated in energy metabolism regulation.
  • Targeting orexin receptors may offer a novel therapeutic strategy for managing obesity and associated metabolic dysfunctions.